转自：北京日报客户端 2025年度即将收官，12月IPO审核继续提速。12月22日—26日这周，沪深北交易所中，三瑞智能、新恒 泰、福恩股份、普昂医疗、隆源股份、大普微、视涯科技、盛龙股份、英氏控股9家企业被安排上会， 单周9家企业首发上会再创年内新高。其中，英氏控股12月22日上会获得通过。从募资额来看，拟募资 金额最高的是闯关科创板的视涯科技，公司拟募集资金约20.15亿元。另外值得一提的是，将于12月25 日上会的大普微，系创业板首单未盈利企业IPO。除即将上会企业外，经同花顺iFinD统计，截至12月22 日，12月已有17家IPO企业上会并获得通过。 单周审核家数再创新高 年内安排上会的IPO企业数量再扩容，沪深北交易所将迎来三瑞智能、新恒泰、福恩股份等9家上会企 业。 经同花顺iFinD统计，在上述9家企业中，上交所、深交所、北交所IPO企业分别有1家、4家、4家。按沪 深板块分布来看，闯关主板、创业板、科创板的分别有2家、2家、1家。 从上会时间来看，12月22日，英氏控股北交所IPO将率先赴考，公司IPO当日上会获得通过。据了解， 英氏控股是一家以满足中国婴幼儿的营养照护需求为核心，婴童食品及 ...

Group 1 - The capital market in Shenzhen has nurtured a high-quality group of listed companies, with 425 A-share listed companies and 159 overseas listed companies ranked among the top in comprehensive competitive strength [1] - As of August 15, 16 Shenzhen enterprises are in the process of applying for A-share IPOs, indicating a growing trend of technology innovation companies seeking public funding [2][5] - The IPO candidates include 6 companies aiming for the Shenzhen Stock Exchange, 3 for the Shanghai Stock Exchange's Sci-Tech Innovation Board, and 7 for the Beijing Stock Exchange, with 15 already in the inquiry stage [2] Group 2 - Among the IPO candidates, Huike Co., Ltd. stands out with total assets exceeding 100 billion yuan and projected revenue of 40.31 billion yuan in 2024, aiming to enhance its core competitiveness through increased R&D investment [2][4] - Hengyun Chang is noted for its rapid growth, with a compound annual growth rate (CAGR) of 84.91% in revenue and 156.72% in net profit from 2022 to 2024, focusing on semiconductor equipment manufacturing [4] - Many of the 16 companies have substantial orders and are looking to expand capacity or enter global markets, indicating a strong demand for their products [4] Group 3 - Shenzhen's listed companies have a significant focus on R&D, with over 50% of the 425 listed companies in the technology innovation sector, reflecting a trend towards high-quality production capabilities [5] - Companies like Kairui Zhi have invested heavily in R&D, achieving 615.34 million yuan in R&D expenses over three years and holding 247 patents, which strengthens their competitive edge [6] - The average gross margin for companies applying for the Sci-Tech Innovation Board and the Growth Enterprise Market is between 40% and 60%, showcasing their resilience in a changing market [6] Group 4 - The capital market is becoming more inclusive, allowing more "hard tech" companies to access funding, with new listing standards accommodating unprofitable but high-growth firms [7] - Companies like Beixin Life and Dapu Micro are examples of firms with rapid growth despite not being profitable, with Beixin Life's revenue projected to grow from 92.45 million yuan in 2022 to 317 million yuan in 2024 [7] - Dapu Micro focuses on enterprise-level SSD products and has seen its market scale grow rapidly, driven by the demand from artificial intelligence applications [7]